ARS Wealth Advisors Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
ARS Wealth Advisors Group's LLY Position: Q3 2026 in Review
ARS Wealth Advisors Group reduced its Eli Lilly (LLY) stake by 0.27% in Q3 2026, selling an estimated $7.08K and leaving 2,255 shares worth $2.61M. The position accounts for 0.19% of the portfolio, ranked #59.
ARS Wealth Advisors Group first reported a position in LLY in Q3 2021 and has held it in 21 quarters since. The position peaked at $2.71M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- ARS Wealth Advisors Group held 2,255 shares of Eli Lilly worth $2.61M as of Q3 2026.
- ARS Wealth Advisors Group sold 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
- Eli Lilly made up 0.19% of ARS Wealth Advisors Group's portfolio in Q3 2026, its #59 holding.
- ARS Wealth Advisors Group first reported a position in Eli Lilly in Q3 2021 and has held it in 21 quarters since.
- ARS Wealth Advisors Group's Eli Lilly position peaked at $2.71M in Q2 2026.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on ARS Wealth Advisors Group's 13F filing for Q3 2026, filed 16 Oct 2026.